» Articles » PMID: 24451150

Implementation of EUnetHTA Core Model® in Lombardia: the VTS Framework

Overview
Date 2014 Jan 24
PMID 24451150
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study describes the health technology assessment (HTA) framework introduced by Regione Lombardia to regulate the introduction of new technologies. The study outlines the process and dimensions adopted to prioritize, assess and appraise the requests of new technologies.

Methods: The HTA framework incorporates and adapts elements from the EUnetHTA Core Model and the EVIDEM framework. It includes dimensions, topics, and issues provided by EUnetHTA Core Model to collect data and process the assessment. Decision making is instead supported by the criteria and Multi-Criteria Decision Analysis technique from the EVIDEM consortium.

Results: The HTA framework moves along three process stages: (i) prioritization of requests, (ii) assessment of prioritized technology, (iii) appraisal of technology in support of decision making. Requests received by Regione Lombardia are first prioritized according to their relevance along eight dimensions (e.g., costs, efficiency and efficacy, organizational impact, safety). Evidence about the impacts of the prioritized technologies is then collected following the issues and topics provided by EUnetHTA Core Model. Finally, the Multi-Criteria Decision Analysis technique is used to appraise the novel technology and support Regione Lombardia decision making.

Conclusions: The VTS (Valutazione delle Tecnologie Sanitarie) framework has been successfully implemented at the end of 2011. From its inception, twenty-six technologies have been processed.

Citing Articles

Synthesis of relevant information around non-core domains to support Multi-Criteria Decision Analysis (MCDA) for decision making.

Bayon-Yusta J, Gutierrez-Iglesias A, Galnares-Cordero L, Gutierrez-Ibarluzea I GMS Health Innov Technol. 2024; 18:Doc02.

PMID: 38655192 PMC: 11035910. DOI: 10.3205/hta000139.


A health technology assessment of personalized nutrition interventions using the EUnetHTA HTA Core Model.

Galekop M, Del Bas J, Calder P, Uyl-de Groot C, Redekop W Int J Technol Assess Health Care. 2024; 40(1):e15.

PMID: 38444327 PMC: 11569966. DOI: 10.1017/S0266462324000060.


Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Parmar A, Dai W, Dionne F, Geirnaert M, Denburg A, Ahuja T Curr Oncol. 2023; 30(4):3776-3786.

PMID: 37185399 PMC: 10137247. DOI: 10.3390/curroncol30040286.


Identifying Attributes for a Value Assessment Framework in China: A Qualitative Study.

Zhang M, Bao Y, Yang Y, Kimber M, Levine M, Xie F Pharmacoeconomics. 2023; 41(4):439-455.

PMID: 36729295 PMC: 9893981. DOI: 10.1007/s40273-022-01235-6.


Societal preferences for funding orphan drugs in China: An application of the discrete choice experiment method.

Tan S, Wang Y, Tang Y, Jiang R, Chen M, Chen H Front Public Health. 2022; 10:1005453.

PMID: 36579068 PMC: 9790908. DOI: 10.3389/fpubh.2022.1005453.